These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5168643)

  • 1. [Antibiotics and myasthenia gravis].
    Igata A
    Shinkei Kenkyu No Shimpo; 1971; 15(4):910-3. PubMed ID: 5168643
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems of antibiotic administration in myasthenia gravis].
    Onishi A; Shida K; Kuroiwa Y
    Shinkei Kenkyu No Shimpo; 1971; 15(4):906-10. PubMed ID: 4334475
    [No Abstract]   [Full Text] [Related]  

  • 3. [Case of long term administration of anti-cholinesterase preparations, with special reference to problems of the neuromuscular endplate].
    Segawa M
    Nihon Rinsho; 1973 Feb; 31(2):364-9. PubMed ID: 4737120
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication)].
    Jurenić D; Jusić A
    Neurologija; 1978; 26(1-4):37-9. PubMed ID: 754038
    [No Abstract]   [Full Text] [Related]  

  • 5. Myasthenia gravis: medical, surgical and anesthetic considerations.
    Vautrinot B
    AANA J; 1979 Aug; 47(4):431-41. PubMed ID: 495032
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adverse effects of therapeutic drugs on neuromuscular junctions].
    Motomura M; Shiraishi H; Yoshimura T; Tsujihata M
    Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1604-7. PubMed ID: 17802708
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological basis for the treatment of myasthenia gravis.
    Flacke W
    Pharmacol Physicians; 1970 Jun; 4(6):1-7. PubMed ID: 4316342
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myasthenia gravis and antibiotics].
    Hashimoto Y; Sasaki H; Yoshinari M; Iwatsuki K
    Masui; 1977 Feb; 26(2):143-8. PubMed ID: 557579
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse drug effects on neuromuscular transmission.
    Howard JF
    Semin Neurol; 1990 Mar; 10(1):89-102. PubMed ID: 2161128
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
    Brown JC; Johns RJ
    Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
    [No Abstract]   [Full Text] [Related]  

  • 12. Hazard from antibiotics in myasthenia gravis.
    McQuillen MP
    Ann Intern Med; 1970 Sep; 73(3):487-8. PubMed ID: 4318447
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Grob test in myasthenia: discussion of an atypical case].
    Gambi D; Tonali P
    Riv Neurol; 1971; 41(3):161-9. PubMed ID: 4331238
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and pharmacological examination of neuromuscular transmission].
    Defféminis Rospide HA; Scarabino R; Silva Gaudin E
    Acta Neurol Latinoam; 1969; 15(1):117-26. PubMed ID: 4329847
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibiotic treatment in myasthenia gravis].
    Argov Z; Abramsky O
    Harefuah; 1982 Nov; 103(10):255-7. PubMed ID: 7182325
    [No Abstract]   [Full Text] [Related]  

  • 16. [Severity of myasthenia gravis is related to the degree of neuromuscular blocking effect by isoflurane].
    Kadosaki M; Enzan K; Horiguchi T; Komatsu H; Suzuki M
    Masui; 1993 Jun; 42(6):906-9. PubMed ID: 8320811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax)].
    Cadisch R; Streit E; Hartmann K
    Schweiz Med Wochenschr; 1996 Feb; 126(8):308-10. PubMed ID: 8701248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Further observations on side effects of intravenous administration of reverin in myasthenia gravis pseudoparalytica].
    Gibbels E
    Dtsch Med Wochenschr; 1967 Jun; 92(25):1153-4. PubMed ID: 6026478
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of myasthenia gravis.
    Dipalma JR
    Am Fam Physician; 1980 Oct; 22(4):158-9. PubMed ID: 7424763
    [No Abstract]   [Full Text] [Related]  

  • 20. Disorders of neuromuscular transmission other than myasthenia gravis.
    Swift TR
    Muscle Nerve; 1981; 4(4):334-53. PubMed ID: 6114428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.